Charles Schwab’s Radius Health, Inc. RDUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-372,315
| Closed | -$3.86M | – | 3587 |
|
|
2022
Q2 | $3.86M | Sell |
372,315
-61,806
| -14% | -$460K | ﹤0.01% | 2302 |
|
|
2022
Q1 | $3.83M | Buy |
434,121
+26,506
| +7% | +$201K | ﹤0.01% | 2400 |
|
|
2021
Q4 | $2.82M | Buy |
407,615
+32,458
| +9% | +$476K | ﹤0.01% | 2586 |
|
|
2021
Q3 | $4.66M | Buy |
375,157
+2,237
| +0.6% | +$32.2K | ﹤0.01% | 2412 |
|
|
2021
Q2 | $6.8M | Buy |
372,920
+9,018
| +2% | +$179K | ﹤0.01% | 2199 |
|
|
2021
Q1 | $7.59M | Sell |
363,902
-30,910
| -8% | -$651K | ﹤0.01% | 2089 |
|
|
2020
Q4 | $7.05M | Sell |
394,812
-48,429
| -11% | -$727K | ﹤0.01% | 2053 |
|
|
2020
Q3 | $5.03M | Buy |
443,241
+43,276
| +11% | +$535K | ﹤0.01% | 2054 |
|
|
2020
Q2 | $5.45M | Buy |
399,965
+62,158
| +18% | +$856K | ﹤0.01% | 1986 |
|
|
2020
Q1 | $4.39M | Buy |
337,807
+3,403
| +1% | +$60.7K | ﹤0.01% | 1898 |
|
|
2019
Q4 | $6.74M | Sell |
334,404
-5,858
| -2% | -$142K | ﹤0.01% | 1865 |
|
|
2019
Q3 | $8.76M | Buy |
340,262
+87,792
| +35% | +$2.15M | 0.01% | 1680 |
|
|
2019
Q2 | $6.15M | Buy |
252,470
+16,474
| +7% | +$360K | ﹤0.01% | 1873 |
|
|
2019
Q1 | $4.71M | Buy |
235,996
+10,238
| +5% | +$187K | ﹤0.01% | 2004 |
|
|
2018
Q4 | $3.72M | Sell |
225,758
-2,636
| -1% | -$44.4K | ﹤0.01% | 2055 |
|
|
2018
Q3 | $4.07M | Buy |
228,394
+11,242
| +5% | +$254K | ﹤0.01% | 2163 |
|
|
2018
Q2 | $6.4M | Buy |
217,152
+25,642
| +13% | +$810K | ﹤0.01% | 1868 |
|
|
2018
Q1 | $6.88M | Buy |
191,510
+8,935
| +5% | +$323K | 0.01% | 1764 |
|
|
2017
Q4 | $5.8M | Buy |
182,575
+1,674
| +0.9% | +$52.5K | ﹤0.01% | 1850 |
|
|
2017
Q3 | $6.97M | Buy |
180,901
+40,006
| +28% | +$1.57M | 0.01% | 1698 |
|
|
2017
Q2 | $6.37M | Sell |
140,895
-8,026
| -5% | -$307K | 0.01% | 1662 |
|
|
2017
Q1 | $5.76M | Buy |
148,921
+8,526
| +6% | +$358K | 0.01% | 1677 |
|
|
2016
Q4 | $5.34M | Buy |
140,395
+7,816
| +6% | +$372K | 0.01% | 1701 |
|
|
2016
Q3 | $7.17M | Buy |
132,579
+27,322
| +26% | +$1.39M | 0.01% | 1409 |
|
|
2016
Q2 | $3.87M | Sell |
105,257
-7,460
| -7% | -$263K | ﹤0.01% | 1726 |
|
|
2016
Q1 | $3.54M | Buy |
112,717
+2,241
| +2% | +$77.5K | ﹤0.01% | 1728 |
|
|
2015
Q4 | $6.8M | Buy |
110,476
+13,165
| +14% | +$831K | 0.01% | 1312 |
|
|
2015
Q3 | $6.75M | Buy |
97,311
+54,997
| +130% | +$3.82M | 0.01% | 1267 |
|
|
2015
Q2 | $2.87M | Buy |
42,314
+28,714
| +211% | +$1.34M | ﹤0.01% | 1894 |
|
|
2015
Q1 | $560K | Buy |
13,600
+3,000
| +28% | +$135K | ﹤0.01% | 2591 |
|
|
2014
Q4 | $413K | Buy |
+10,600
| New | +$251K | ﹤0.01% | 2704 |
|
Other funds holding RDUS
Charles Schwab's RDUS Position: Q3 2022 in Review
Charles Schwab sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 372,315 shares — an estimated $3.86M sold.
Charles Schwab first reported a position in RDUS in Q4 2014 and held it in 31 quarters. The position peaked at $8.76M in Q3 2019. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.
- Charles Schwab reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
- Charles Schwab sold 372,315 Radius Health, Inc. shares in Q3 2022, an estimated $3.86M.
- Charles Schwab first reported a position in Radius Health, Inc. in Q4 2014 and held it in 31 quarters.
- Charles Schwab's Radius Health, Inc. position peaked at $8.76M in Q3 2019.
- 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.
Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.